Intel announced and initiated its 2025 Restructuring Plan in Q2 2025 and said it expects to recognize total charges of approximately $1.9 billion, with cumulative charges as of June 28, 2025 of $1.8 billion.

10-QQuarterly reportFiled Jul 24, 2025Period of report Jun 28, 2025Summary published (UTC) Oct 10, 2026

Key points

AI summary

Intel announced and initiated its 2025 Restructuring Plan in Q2 2025 and said it expects to recognize total charges of approximately $1.9 billion, with cumulative charges as of June 28, 2025 of $1.8 billion.
In Q2 2025, the company determined that its manufacturing asset portfolio exceeded required capacity and recognized a non-cash impairment of $460 million and accelerated depreciation of $337 million in cost of sales for the Intel Foundry segment, on a net basis excluding certain items.
Intel entered into an agreement on April 14, 2025 to sell 51% of all issued and outstanding common stock of Altera, a wholly owned subsidiary, and said the transaction is expected to close in the second half of 2025, subject to regulatory approvals and other customary closing conditions.
Intel recognized CHIPS Act grants of $890 million in the first six months of 2025, of which capital-related incentives of $742 million reduced gross property, plant, and equipment and operating-related incentives of $148 million contributed to operating income, the company said.

Key figures

Quarter ended June 28, 2025

Revenue: $12.9B
Operating income: −$3.2B
Net income: −$2.9B
EPS: −$0.67
Gross profit: $3.5B

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

2025 Restructuring Plan and Cumulative Charges

Intel announced and initiated its 2025 Restructuring Plan in Q2 2025 and said it expects to recognize total charges of approximately $1.9 billion, with cumulative charges as of June 28, 2025 of $1.8 billion.

Source · Based on the MD&A text of the filing

Manufacturing Asset Impairment and Accelerated Depreciation

In Q2 2025, the company determined that its manufacturing asset portfolio exceeded required capacity and recognized a non-cash impairment of $460 million and accelerated depreciation of $337 million in cost of sales for the Intel Foundry segment, on a net basis excluding certain items.

Source · Based on the MD&A text of the filing

Agreement to Sell 51% Controlling Interest in Altera

Intel entered into an agreement on April 14, 2025 to sell 51% of all issued and outstanding common stock of Altera, a wholly owned subsidiary, and said the transaction is expected to close in the second half of 2025, subject to regulatory approvals and other customary closing conditions.

Source · Based on the MD&A text of the filing

CHIPS Act Grant Recognition

Intel recognized CHIPS Act grants of $890 million in the first six months of 2025, of which capital-related incentives of $742 million reduced gross property, plant, and equipment and operating-related incentives of $148 million contributed to operating income, the company said.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗